BACKGROUND: Cellular phone conversations between on-scene patients or their legally authorized representatives (LARs) and off-scene enrolling physician-investigators require immediate and reliable connection systems to obtain explicit informed research consent in prehospital treatment trials. METHODS: The NIH Field Administration of Stroke Therapy-Magnesium (FAST-MAG) Trial implemented a voice-over-internet protocol (VOIP) simultaneous ring system (multiple investigator cell phones called simultaneously and first responder connected to call) to enable physician-investigators to elicit consent immediately from competent patients or LARs encountered by 228 ambulances enrolling patients in a multicenter prehospital stroke trial. For 1 month, the number, origin, duration, and yield of enrolling line calls were monitored prospectively. RESULTS: Six investigators were connected to 106 enrolling line calls, with no identified unanswered calls. Thirty-five percent of new patient calls yielded an enrollment. The most common reasons for non-enrollment were last known well >2 h (n = 7) and unconsentable patient without LAR available (n = 7). No non-enrollments were directly attributable to the VOIP system. In enrollments, consent was provided by the patient in 67% and a LAR in 33%. The duration of enrollment calls (mean +/- SD: 8.4 +/- 2.5 min, range 6-14) was longer than non-enrollment calls (5.5 +/- 3.5, range 2-13; p < 0.001). The median interval from last known well to study agent start was 46 min, and 70% were enrolled within 60 min of onset. CONCLUSIONS: The simultaneous ring system was reliable and effective, permitting enrollment of a substantial number of patients within the first hour after stroke onset. VOIP cellular networks with simultaneous ring are a preferred means of facilitating consent in prehospital treatment trials. Copyright (c) 2009 S. Karger AG, Basel.
BACKGROUND: Cellular phone conversations between on-scene patients or their legally authorized representatives (LARs) and off-scene enrolling physician-investigators require immediate and reliable connection systems to obtain explicit informed research consent in prehospital treatment trials. METHODS: The NIH Field Administration of Stroke Therapy-Magnesium (FAST-MAG) Trial implemented a voice-over-internet protocol (VOIP) simultaneous ring system (multiple investigator cell phones called simultaneously and first responder connected to call) to enable physician-investigators to elicit consent immediately from competent patients or LARs encountered by 228 ambulances enrolling patients in a multicenter prehospital stroke trial. For 1 month, the number, origin, duration, and yield of enrolling line calls were monitored prospectively. RESULTS: Six investigators were connected to 106 enrolling line calls, with no identified unanswered calls. Thirty-five percent of new patient calls yielded an enrollment. The most common reasons for non-enrollment were last known well >2 h (n = 7) and unconsentable patient without LAR available (n = 7). No non-enrollments were directly attributable to the VOIP system. In enrollments, consent was provided by the patient in 67% and a LAR in 33%. The duration of enrollment calls (mean +/- SD: 8.4 +/- 2.5 min, range 6-14) was longer than non-enrollment calls (5.5 +/- 3.5, range 2-13; p < 0.001). The median interval from last known well to study agent start was 46 min, and 70% were enrolled within 60 min of onset. CONCLUSIONS: The simultaneous ring system was reliable and effective, permitting enrollment of a substantial number of patients within the first hour after stroke onset. VOIP cellular networks with simultaneous ring are a preferred means of facilitating consent in prehospital treatment trials. Copyright (c) 2009 S. Karger AG, Basel.
Authors: Jeffrey L Saver; Chelsea Kidwell; Marc Eckstein; Bruce Ovbiagele; Sidney Starkman Journal: Prehosp Emerg Care Date: 2006 Apr-Jun Impact factor: 3.077
Authors: Donald G Rosenberg; Esther Levin; Ana Lausell; Allen Brown; John Gardner; Esther Perez; Mark Veenendaal; Yee S C Ong; Mary Gunn Journal: J Thromb Thrombolysis Date: 2002-06 Impact factor: 2.300
Authors: Piotr Iwanowski; Andrzej Budaj; Anna Członkowska; Wojciech Wasek; Beata Kozłowska-Boszko; Urszula Oledzka; Wojciech Masełbas Journal: Trials Date: 2008-07-21 Impact factor: 2.279
Authors: Nerses Sanossian; Sidney Starkman; Mark Eckstein; Samuel Stratton; Frank Pratt; Robin Conwit; Jeffrey L Saver Journal: Cerebrovasc Dis Date: 2010-07-28 Impact factor: 2.762
Authors: Duika L Burges Watson; Randy Sanoff; Joan E Mackintosh; Jeffrey L Saver; Gary A Ford; Christopher Price; Sidney Starkman; Marc Eckstein; Robin Conwit; Anna Grace; Madeleine J Murtagh Journal: Ann Emerg Med Date: 2012-03-03 Impact factor: 5.721
Authors: Jeffrey L Saver; Sidney Starkman; Marc Eckstein; Samuel Stratton; Frank Pratt; Scott Hamilton; Robin Conwit; David S Liebeskind; Gene Sung; Nerses Sanossian Journal: Int J Stroke Date: 2014-02 Impact factor: 5.266
Authors: Kristina Shkirkova; Jeffrey L Saver; Sidney Starkman; Gregory Wong; Julius Weng; Scott Hamilton; David S Liebeskind; Marc Eckstein; Samuel Stratton; Frank Pratt; Robin Conwit; Nerses Sanossian Journal: JAMA Neurol Date: 2018-11-01 Impact factor: 18.302
Authors: Dae-Hyun Kim; Jeffrey L Saver; Sidney Starkman; David S Liebeskind; Latisha K Ali; Lucas Restrepo; May Kim-Tenser; Miguel Valdes-Sueiras; Marc Eckstein; Frank Pratt; Samuel Stratton; Scott Hamilton; Robin Conwit; Nerses Sanossian Journal: Stroke Date: 2015-12-10 Impact factor: 7.914
Authors: Jeffrey L Saver; Tudor G Jovin; Wade S Smith; Gregory W Albers; Jean-Claude Baron; Johannes Boltze; Joseph P Broderick; Lisa A Davis; Andrew M Demchuk; Salvatore DeSena; Jens Fiehler; Philip B Gorelick; Werner Hacke; Bill Holt; Reza Jahan; Hui Jing; Pooja Khatri; Chelsea S Kidwell; Kennedy R Lees; Michael H Lev; David S Liebeskind; Marie Luby; Patrick Lyden; J Thomas Megerian; J Mocco; Keith W Muir; Howard A Rowley; Richard M Ruedy; Sean I Savitz; Vitas J Sipelis; Samuel K Shimp; Lawrence R Wechsler; Max Wintermark; Ona Wu; Dileep R Yavagal; Albert J Yoo Journal: Stroke Date: 2013-11-05 Impact factor: 7.914
Authors: José G Merino; Marie Luby; Richard T Benson; Lisa A Davis; Amie W Hsia; Lawrence L Latour; John K Lynch; Steven Warach Journal: J Stroke Cerebrovasc Dis Date: 2013-05-13 Impact factor: 2.136